{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T13:28:31Z","timestamp":1793194111728,"version":"4.5.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T00:00:00Z","timestamp":1588032000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T00:00:00Z","timestamp":1588032000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Bosniak III and IV cysts have a high risk of malignancy and have traditionally been managed surgically. However, growing evidence suggests that many can be managed by active surveillance. The main objective of this study was to characterize the use of surveillance in the management of complex renal cysts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A web-based survey was sent to all registered, active members of the Canadian Urological Association (\n                      <jats:italic>N<\/jats:italic>\n                      \u2009=\u2009583) in October 2018.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The survey response rate was 24.7%. Management of Bosniak III cysts varied considerably. A large proportion of respondents (33.1%) offered active surveillance in &gt;\u200950% of cases. Only 13.7% of respondents reported never or rarely (&lt;\u20095% of cases) offering surveillance. In contrast, for Bosniak IV cysts, 60.1% of urologists never or rarely offered surveillance, while only 10.1% offer it in &gt;\u200950% of cases. A significantly greater proportion of academic urologists, compared to non-academic urologists, viewed surveillance as a management option for patients with a Bosniak III or IV cyst. The most commonly reported barriers to a greater adoption of surveillance were concerns regarding its oncologic safety, the lack of data to support surveillance in this population, and the lack of triggers for discontinuation of active surveillance and intervention.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Despite active surveillance being included as a management option in guidelines, many Canadian urologists are reluctant to offer surveillance to patients with Bosniak III or IV cysts. Practice patterns are heterogeneous among those offering surveillance. High-quality studies are required to better define the benefits and risks of cystic renal mass surveillance.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12894-020-00614-5","type":"journal-article","created":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T14:04:26Z","timestamp":1588082666000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Management of complex renal cysts in Canada: results of a survey study"],"prefix":"10.1186","volume":"20","author":[{"given":"F\u00e9lix","family":"Couture","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Finelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Am\u00e9lie","family":"T\u00e9tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bimal","family":"Bhindi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney H.","family":"Breau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wassim","family":"Kassouf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"Lavall\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Tanguay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe D.","family":"Violette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick O.","family":"Richard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,28]]},"reference":[{"key":"614_CR1","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1046\/j.1442-2042.2003.00577.x","volume":"10","author":"K Marumo","year":"2003","unstructured":"Marumo K, Horiguchi Y, Nakagawa K, Oya M, Ohigashi T, Asakura H, et al. Incidence and growth pattern of simple cysts of the kidney in patients with asymptomatic microscopic hematuria. Int J Urol. 2003;10:63\u20137.","journal-title":"Int J Urol"},{"key":"614_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1148\/radiology.158.1.3510019","volume":"158","author":"M Bosniak","year":"1986","unstructured":"Bosniak M. The current radiological approach to renal cysts. Radiology. 1986;158:1\u201310.","journal-title":"Radiology."},{"key":"614_CR3","doi-asserted-by":"publisher","first-page":"819","DOI":"10.2214\/ajr.169.3.9275903","volume":"169","author":"M Bosniak","year":"1997","unstructured":"Bosniak M. Diagnosis and Management of Patients with complicated cystic lesions of the kidney. AJR. 1997;169:819\u201321.","journal-title":"AJR."},{"key":"614_CR4","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.urology.2005.04.003","volume":"66","author":"GM Israel","year":"2005","unstructured":"Israel GM, Bosniak MA. An update on the Bosniak renal cyst classification system. Urology. 2005;66:484\u20139.","journal-title":"Urology."},{"key":"614_CR5","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1016\/j.juro.2016.05.118","volume":"196","author":"JR Bhatt","year":"2016","unstructured":"Bhatt JR, Jewett M, Richard PO, Kawaguchi S, Timilshina N, Evans A, et al. Multilocular cystic renal cell carcinoma: pathological T staging makes no difference to favorable outcomes and should be reclassified. J Urol. 2016;196:1350\u20135.","journal-title":"J Urol"},{"key":"614_CR6","doi-asserted-by":"publisher","first-page":"E66","DOI":"10.5489\/cuaj.4484","volume":"11","author":"PO Richard","year":"2017","unstructured":"Richard PO, Violette PD, Jewett MAS, Pouliot F, Leveridge MJ, So A, et al. CUA guideline on the management of cystic renal lesions. Can Urol Assoc J. 2017;11:E66\u201373.","journal-title":"Can Urol Assoc J"},{"key":"614_CR7","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.juro.2016.09.160","volume":"198","author":"IG Schoots","year":"2017","unstructured":"Schoots IG, Zaccai K, Hunink MG, Verhagen P. Bosniak classification for complex renal cysts reevaluated: a systematic review. J Urol. 2017;198:12\u201321.","journal-title":"J Urol"},{"key":"614_CR8","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.clgc.2014.06.018","volume":"13","author":"NM Donin","year":"2015","unstructured":"Donin NM, Mohan S, Pham H, Chandarana H, Doshi A, Deng F-M, et al. Clinicopathologic outcomes of cystic renal cell carcinoma. Clin Genitourin Cancer. 2015;13:67\u201370..","journal-title":"Clin Genitourin Cancer"},{"key":"614_CR9","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s00432-007-0302-1","volume":"134","author":"K Gong","year":"2008","unstructured":"Gong K, Zhang N, He Z, Zhou L, Lin G, Na Y. Multilocular cystic renal cell carcinoma: an experience of clinical management for 31 cases. J Cancer Res Clin Oncol. 2008;134:433\u20137.","journal-title":"J Cancer Res Clin Oncol"},{"key":"614_CR10","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/S0090-4295(02)01742-9","volume":"60","author":"A Nassir","year":"2002","unstructured":"Nassir A, Jollimore J, Gupta R, Bell D, Norman R. Multilocular cystic renal cell carcinoma: a series of 12 cases and review of the literature. Urology. 2002;60:421\u20137.","journal-title":"Urology."},{"key":"614_CR11","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1016\/j.urolonc.2015.07.017","volume":"33","author":"BR Winters","year":"2015","unstructured":"Winters BR, Gore JL, Holt SK, Harper JD, Lin DW, Wright JL. Cystic renal cell carcinoma carries an excellent prognosis regardless of tumor size. Urol Oncol. 2015;33:e9\u201313.","journal-title":"Urol Oncol"},{"key":"614_CR12","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1046\/j.1464-410x.1998.00689.x","volume":"82","author":"O Bielsa","year":"1998","unstructured":"Bielsa O, Lloreta J, Gelabert-Mas A. Cystic renal cell carcinoma: pathological features, survival and implications for treatment. Br J Urol. 1998;82:16\u201320.","journal-title":"Br J Urol"},{"key":"614_CR13","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/S0022-5347(01)61903-7","volume":"161","author":"FA Corica","year":"1999","unstructured":"Corica FA, Iczkowski KA, Cheng L, Zincke H, Blute ML, Wendel A, et al. Cystic renal cell carcinoma is cured by resection: a study of 24 cases with long-term followup. J Urol. 1999;161:408\u201311.","journal-title":"J Urol"},{"key":"614_CR14","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0090-4295(00)00540-9","volume":"56","author":"S Koga","year":"2000","unstructured":"Koga S, Nishikido M, Hayashi T, Matsuya F, Saito Y, Kanetake H. Outcome of surgery in cystic renal cell carcinoma. Urology. 2000;56:67\u201370.","journal-title":"Urology."},{"key":"614_CR15","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1093\/ajcp\/95.5.633","volume":"95","author":"T Murad","year":"1991","unstructured":"Murad T, Komaiko W, Oyasu R, Bauer K. Multilocular cystic renal cell carcinoma. Am J Clin Pathol. 1991;95:633\u20137.","journal-title":"Am J Clin Pathol"},{"key":"614_CR16","doi-asserted-by":"crossref","unstructured":"Ljungberg B, Albiges L, Abu-Ghanem Y, Bensalah K, Dabestani S, Fernandez-Pello S, et al. European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update. Eur Urol. 2019;75(5):799\u2013810.","DOI":"10.1016\/j.eururo.2019.02.011"},{"key":"614_CR17","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.juro.2017.09.078","volume":"199","author":"T Chandrasekar","year":"2018","unstructured":"Chandrasekar T, Ahmad A, Fadaak K, Jhaveri K, Bhatt J, Jewett M, et al. Natural history of complex renal cysts: clinical evidence supporting active surveillance. J Urol. 2018;199:633\u201340.","journal-title":"J Urol"},{"key":"614_CR18","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/j.juro.2018.07.063","volume":"200","author":"D Pruthi","year":"2018","unstructured":"Pruthi D, Liu Q, Kirkpatrick I, Gelfond J, Drachenberg D. Long-term surveillance of complex cystic renal masses and heterogeneity of Bosniak 3 lesions. J Urol. 2018;200:1192\u20139.","journal-title":"J Urol"},{"issue":"3","key":"614_CR19","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1503\/cmaj.080372","volume":"179","author":"KE Burns","year":"2008","unstructured":"Burns KE, Duffett M, Kho ME, Meade MO, Adhikari NK, Sinuff T, et al. A guide for the design and conduct of self-administered surveys of clinicians. CMAJ. 2008;179(3):245\u201352.","journal-title":"CMAJ."},{"issue":"3","key":"614_CR20","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.2196\/jmir.6.3.e34","volume":"6","author":"G Eysenbach","year":"2004","unstructured":"Eysenbach G. Improving the quality of web surveys: the checklist for reporting results of internet E-surveys (CHERRIES). J Med Internet Res. 2004;6(3):e34.","journal-title":"J Med Internet Res"},{"key":"614_CR21","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.eururo.2018.06.003","volume":"74","author":"B Bhindi","year":"2018","unstructured":"Bhindi B, Thompson R, Lohse C, Mason R, Frank I, Costello B, et al. The probability of aggressive versus indolent histology based on renal tumor size: implications for surveillance and treatment. Eur Urol. 2018;74:489\u201397.","journal-title":"Eur Urol"},{"key":"614_CR22","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1200\/JCO.2016.69.9645","volume":"35","author":"A Finelli","year":"2017","unstructured":"Finelli A, Ismaila N, Bro B, Durack J, Eggener S, Evans A, et al. Management of small renal masses: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2017;35:668\u201380.","journal-title":"J Clin Oncol"},{"key":"614_CR23","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.eururo.2011.03.030","volume":"60","author":"MA Jewett","year":"2011","unstructured":"Jewett MA, Mattar K, Basiuk J, Morash CG, Pautler SE, Siemens DR, et al. Active surveillance of small renal masses: progression patterns of early stage kidney cancer. Eur Urol. 2011;60:39\u201344.","journal-title":"Eur Urol"},{"key":"614_CR24","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.eururo.2015.02.001","volume":"68","author":"PM Pierorazio","year":"2015","unstructured":"Pierorazio PM, Johnson MH, Ball MW, Gorin MA, Trock BJ, Chang P, et al. Five-year analysis of a multi-institutional prospective clinical trial of delayed intervention and surveillance for small renal masses: the DISSRM registry. Eur Urol. 2015;68:408\u201315.","journal-title":"Eur Urol"},{"issue":"8","key":"614_CR25","doi-asserted-by":"publisher","first-page":"260","DOI":"10.5489\/cuaj.5065","volume":"12","author":"PO Richard","year":"2018","unstructured":"Richard PO, Martin L, Lavallee LT, Violette PD, Komisarenko M, Evans AJ, et al. Identifying the use and barriers to the adoption of renal tumour biopsy in the management of small renal masses. Can Urol Assoc J. 2018;12(8):260\u20136.","journal-title":"Can Urol Assoc J"},{"issue":"5\u20136","key":"614_CR26","doi-asserted-by":"publisher","first-page":"181","DOI":"10.5489\/cuaj.3608","volume":"10","author":"AC Millar","year":"2016","unstructured":"Millar AC, Elterman DS, Goldenberg L, Van Asseldonk B, Curtis A, Jarvi K. A survey of Canadian urologists' opinions and prescribing patterns of testosterone replacement therapy in men on active surveillance for low-risk prostate cancer. Can Urol Assoc J. 2016;10(5\u20136):181\u20134.","journal-title":"Can Urol Assoc J"}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-020-00614-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12894-020-00614-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-020-00614-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T19:31:43Z","timestamp":1619551903000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcurol.biomedcentral.com\/articles\/10.1186\/s12894-020-00614-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,28]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["614"],"URL":"https:\/\/doi.org\/10.1186\/s12894-020-00614-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.21790\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.21790\/v1","asserted-by":"object"}]},"ISSN":["1471-2490"],"issn-type":[{"value":"1471-2490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,28]]},"assertion":[{"value":"16 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval was obtained from the CIUSSS de l\u2019Estrie - CHUS Research Ethics Board prior to the dissemination of the survey (IRB approval number MP-31-2019-2876). As stated in the introduction and presentation page of the survey, consent was obtained from participants online, as it was implied upon completion of survey questions.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"WK is a member of the editorial board of BMC Urology. All other authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"47"}}